Teams at Lindus Therapeutics

Senior individual contributor responsible for statistical leadership across a portfolio of clinical-stage assets: due diligence for acquisitions, complex trial design (including adaptive/multi-cohort), high-stakes interim and final analyses, regulatory representation and submissions, and building statistical standards, templates and mentorship for the biostatistics function.

Leads statistical strategy across a clinical-stage biopharma portfolio while remaining hands-on across protocols, analyses, database lock, and clinical study reports. Represents biostatistics with regulators, oversees statistical programming and medical writing, evaluates external clinical data for licensing, and guides adaptive trial design, submissions, CRO partnerships, and AI/ML workflow innovation. Builds and leads the biostatistics function as the portfolio expands.

Lead development strategy for a portfolio of in-licensed assets toward capital-efficient Phase 2 proof-of-concept readouts. Design Phase 1/2 studies, set target product profiles, drive regulatory and CMC plans, lead diligence and prioritize assets, build and manage a lean virtual development organization, and represent development strategy to investors, partners and the board.